Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385632 · ClinicalTrials.gov registry record
Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,224
- Enrollment target
NCT00385632 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,224 participants.
The verdict
NCT00385632 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,224 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
Interventions
- DRUG Antiretroviral Regimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,224 participants |
| Start Date | 2002-01 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00385632
The ClinicalTrials.gov registry entry for NCT00385632 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Antiretroviral Regimens is the first listed.
NCT00385632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00385632 about?
NCT00385632 is a clinical study titled "Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants". The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
What is the current status of trial NCT00385632?
This trial is currently completed. The enrollment target is 1,224 participants. The study started on 2002-01. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00385632?
The interventions under investigation include: Antiretroviral Regimens (DRUG).
Who is sponsoring clinical trial NCT00385632?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.